Expert Discusses Durvalumab and Future of Immunotherapy in NSCLC

Press/Media: Press / Media

Period	Oct 28 2018

Title Expert Discusses Durvalumab and Future of Immunotherapy in NSCLC
Media name/outlet OncLive
Country United States
Date 10/28/18
Persons Neil Morganstein

Title	Expert Discusses Durvalumab and Future of Immunotherapy in NSCLC
Media name/outlet	OncLive
Country	United States
Date	10/28/18
Persons	Neil Morganstein